Search Orphan Drug Designations and Approvals
-
Generic Name: | Dexpramipexole |
---|---|
Date Designated: | 04/22/2019 |
Orphan Designation: | Treatment of hypereosinophilic syndrome (HES) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Areteia Therapeutics 1200 Morris Turnpike, Suite 3005 Short Hills, New Jersey 07078 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-